BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26592814)

  • 1. X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design.
    St John SE; Therkelsen MD; Nyalapatla PR; Osswald HL; Ghosh AK; Mesecar AD
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5072-7. PubMed ID: 26592814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
    Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
    J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
    Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
    J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
    Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
    Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the active centre of coronavirus 3C-like proteases.
    Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
    J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
    Kim Y; Mandadapu SR; Groutas WC; Chang KO
    Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene.
    Chang HW; de Groot RJ; Egberink HF; Rottier PJ
    J Gen Virol; 2010 Feb; 91(Pt 2):415-20. PubMed ID: 19889934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
    J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
    Wang G; Hu G; Liang R; Shi J; Qiu X; Yang Y; Jiao Z; Chen Y; Shen Z; Li M; Shi Y; Mao J; Peng G
    J Virol; 2021 Oct; 95(21):e0074521. PubMed ID: 34406859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL
    Han SH; Goins CM; Arya T; Shin WJ; Maw J; Hooper A; Sonawane DP; Porter MR; Bannister BE; Crouch RD; Lindsey AA; Lakatos G; Martinez SR; Alvarado J; Akers WS; Wang NS; Jung JU; Macdonald JD; Stauffer SR
    J Med Chem; 2022 Feb; 65(4):2880-2904. PubMed ID: 34347470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor.
    Perera KD; Rathnayake AD; Liu H; Pedersen NC; Groutas WC; Chang KO; Kim Y
    Vet Microbiol; 2019 Oct; 237():108398. PubMed ID: 31585653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS).
    St John SE; Tomar S; Stauffer SR; Mesecar AD
    Bioorg Med Chem; 2015 Sep; 23(17):6036-48. PubMed ID: 26190463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2.
    Dai W; Jochmans D; Xie H; Yang H; Li J; Su H; Chang D; Wang J; Peng J; Zhu L; Nian Y; Hilgenfeld R; Jiang H; Chen K; Zhang L; Xu Y; Neyts J; Liu H
    J Med Chem; 2022 Feb; 65(4):2794-2808. PubMed ID: 33872498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
    Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
    Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
    Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
    Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents.
    Konno S; Kobayashi K; Senda M; Funai Y; Seki Y; Tamai I; Schäkel L; Sakata K; Pillaiyar T; Taguchi A; Taniguchi A; Gütschow M; Müller CE; Takeuchi K; Hirohama M; Kawaguchi A; Kojima M; Senda T; Shirasaka Y; Kamitani W; Hayashi Y
    J Med Chem; 2022 Feb; 65(4):2926-2939. PubMed ID: 34313428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNA replicon system to investigate promising inhibitors of feline coronavirus.
    Schmied K; Ehmann R; Kristen-Burmann C; Ebert N; Barut GT; Almeida L; Kelly JN; Thomann L; Stalder H; Lang R; Tekes G; Thiel V
    J Virol; 2024 Feb; 98(2):e0121623. PubMed ID: 38236006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus.
    Zhou M; Han Y; Li M; Ye G; Peng G
    Virol Sin; 2021 Dec; 36(6):1421-1430. PubMed ID: 34228261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.